Cost effectiveness of interferon α or peginterferon α with ribavirin for histologically mild chronic hepatitis C

BACKGROUND: For patients with mild chronic hepatitis C the cost effectiveness of antiviral therapy is unknown. AIMS: To assess whether antiviral therapy (either interferon α or peginterferon α combined with ribavirin) is cost effective at a mild stage compared with waiting and only treating those ca...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Grieve, R, Roberts, J, Wright, M, Sweeting, M, DeAngelis, D, Rosenberg, W, Bassendine, M, Main, J, Thomas, H
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Group 2006
Gaiak:
Hepatitis
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1860032/
https://ncbi.nlm.nih.gov/pubmed/15994216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2005.064774
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak